MAPK and PI3K Inhibition Reduces Proliferation of Barrett's Adenocarcinoma in Vitro1

Herein, we report significant antiproliferative effects against Barrett's adenocarcinoma by MAPK and PI3K inhibition in vitro. Pro-apoptotic mechanisms prevail in the wild-type p53 cells. Further investigation is warranted to advance the clinical treatment of this devastating disease.